FDA Panel To Review the Amgen’s ABP 501, Biosimilar Candidate To Adalimumab
Amgen announced that the Arthritis Advisory Committee of the U.S. FDA will review data supporting the Company's Biologics License Application (BLA) for ABP 501,...
Eisai presents data on its anti-fractalkine monoclonal antibody E6011
Eisai Co Ltd. announced that interim analyses on the latest data for the world's first anti-fractalkine monoclonal antibody E6011, discovered by Eisai's research subsidiary...
Merck, Pfizer double size of diabetes study to catch rivals
Merck in partnership with Pfizer Inc. announced that two Phase 3 studies (VERTIS Mono and VERTIS Factorial) of ertugliflozin, an investigational oral SGLT-2 inhibitor...
Dr Reddy’s drops as US agency charges firm for packaging lapses
The US CPSC, which is tasked with protecting children and families from risks of injuries or death associated with consumer products, had taken issue...
Merck Expands its Investment Fund Merck Ventures
Merck, a leading science and technology company, announced an increased commitment to its corporate venture fund under the new Merck Ventures roof. ...
GlaxoSmithKline presents new data from Breo Ellipta SUMMIT study in patients with COPD at ATS Conference
GlaxoSmithKline and Innoviva, Inc announced that GlaxoSmithKline plc (GSK) presented new data at the American Thoracic Society (ATS) Conference from two pre-specified analyses from...
Pharma Giant Eli Lilly Wants to Launch 20 New Drugs by 2023
Indianapolis-based pharmaceutical giant Eli Lilly LLY -0.64% laid out an ambitious R&D agenda for launching up to 20 new drugs by 2023 during an...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...